NCT02660424

A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee

A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 124 (actual)
• Sponsor: Vertex Pharmaceuticals Incorporated · Industry
• Sex: All
• Age: 40 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The Primary objective of this study is to evaluate the efficacy of VX-150 in the treatment of osteoarthritis pain

Conditions

• Osteoarthritis

Interventions

Type	Name	Description
DRUG	VX-150
DRUG	Placebo

Timeline

• Start date: 2015-12-01
• Primary completion: 2016-08-01
• Completion: 2016-09-01
• First posted: 2016-01-21
• Last updated: 2020-09-30

Locations

12 sites across 1 country: United States